JAGX
Price
$2.58
Change
+$0.01 (+0.39%)
Updated
Jul 3 closing price
Capitalization
3.42M
LGVN
Price
$1.30
Change
-$0.00 (-0.00%)
Updated
Jul 3 closing price
Capitalization
19.66M
Interact to see
Advertisement

JAGX vs LGVN

Header iconJAGX vs LGVN Comparison
Open Charts JAGX vs LGVNBanner chart's image
Jaguar Health
Price$2.58
Change+$0.01 (+0.39%)
Volume$17.89K
Capitalization3.42M
Longeveron
Price$1.30
Change-$0.00 (-0.00%)
Volume$1.73K
Capitalization19.66M
JAGX vs LGVN Comparison Chart in %
Loading...
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
JAGX vs. LGVN commentary
Jul 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JAGX is a Hold and LGVN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 05, 2025
Stock price -- (JAGX: $2.58 vs. LGVN: $1.30)
Brand notoriety: JAGX and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: JAGX: 17% vs. LGVN: 1%
Market capitalization -- JAGX: $3.42M vs. LGVN: $19.66M
JAGX [@Biotechnology] is valued at $3.42M. LGVN’s [@Biotechnology] market capitalization is $19.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $310.37B to $0. The average market capitalization across the [@Biotechnology] industry is $2.38B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

JAGX’s FA Score shows that 1 FA rating(s) are green whileLGVN’s FA Score has 1 green FA rating(s).

  • JAGX’s FA Score: 1 green, 4 red.
  • LGVN’s FA Score: 1 green, 4 red.
According to our system of comparison, LGVN is a better buy in the long-term than JAGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

JAGX’s TA Score shows that 4 TA indicator(s) are bullish while LGVN’s TA Score has 6 bullish TA indicator(s).

  • JAGX’s TA Score: 4 bullish, 2 bearish.
  • LGVN’s TA Score: 6 bullish, 2 bearish.
According to our system of comparison, LGVN is a better buy in the short-term than JAGX.

Price Growth

JAGX (@Biotechnology) experienced а -4.80% price change this week, while LGVN (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +6.93%. For the same industry, the average monthly price growth was +17.38%, and the average quarterly price growth was -0.11%.

Reported Earning Dates

JAGX is expected to report earnings on May 15, 2025.

LGVN is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (+6.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LGVN($19.7M) has a higher market cap than JAGX($3.42M). LGVN YTD gains are higher at: -24.855 vs. JAGX (-89.782). LGVN has higher annual earnings (EBITDA): -16.49M vs. JAGX (-37.39M). LGVN has more cash in the bank: 14.3M vs. JAGX (5.69M). LGVN has less debt than JAGX: LGVN (1.3M) vs JAGX (38.3M). JAGX has higher revenues than LGVN: JAGX (11.6M) vs LGVN (2.23M).
JAGXLGVNJAGX / LGVN
Capitalization3.42M19.7M17%
EBITDA-37.39M-16.49M227%
Gain YTD-89.782-24.855361%
P/E Ratio0.01N/A-
Revenue11.6M2.23M521%
Total Cash5.69M14.3M40%
Total Debt38.3M1.3M2,958%
FUNDAMENTALS RATINGS
JAGX: Fundamental Ratings
JAGX
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
JAGXLGVN
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
N/A
Bullish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
82%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 3 days ago
89%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SND1.970.01
+0.51%
Smart Sand
DGICB17.31N/A
N/A
Donegal Group
REG70.79-0.01
-0.01%
Regency Centers Corp
WLY43.29-0.11
-0.25%
John Wiley & Sons
ELAB2.24-0.07
-3.03%
PMGC Holdings Inc

JAGX and

Correlation & Price change

A.I.dvisor tells us that JAGX and RNAZ have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that JAGX and RNAZ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAGX
1D Price
Change %
JAGX100%
+0.39%
RNAZ - JAGX
31%
Poorly correlated
+1.93%
DVHGF - JAGX
27%
Poorly correlated
N/A
TAOX - JAGX
26%
Poorly correlated
+5.20%
SLNO - JAGX
26%
Poorly correlated
+0.51%
ACET - JAGX
26%
Poorly correlated
-1.14%
More

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with QURE. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
N/A
QURE - LGVN
37%
Loosely correlated
+0.98%
LGND - LGVN
34%
Loosely correlated
+0.81%
SNGX - LGVN
34%
Loosely correlated
-4.76%
SRPT - LGVN
34%
Loosely correlated
+0.25%
KZIA - LGVN
32%
Poorly correlated
N/A
More